AAAAAA
Results:
1-10
|
Results: 10
Authors:
Henn, AD
Berleth, ES
Mihich, E
Ehrke, MJ
Citation: Ad. Henn et al., Changes in cytosolic and membrane TNF inhibitory protein-B1 (TIP-B1) levels associated with protection from TNF-induced cytotoxicity, FASEB J, 15(7), 2001, pp. 1315-1317
Authors:
Berleth, ES
Masso-Welch, PA
Kazim, LA
Ip, MM
Mihich, E
Ehrke, MJ
Citation: Es. Berleth et al., Expression, tissue distribution, and cellular localization of the antiapoptotic TIP-B1 protein, J LEUK BIOL, 69(6), 2001, pp. 995-1005
Authors:
Mihich, E
Citation: E. Mihich, Historical overview of biologic response modifiers, CANCER INV, 18(5), 2000, pp. 456-466
Authors:
Mihich, E
Citation: E. Mihich, On the immunomodulating effects of anti-cancer drugs and their therapeuticexploitation, JPN J CLIN, 30(11), 2000, pp. 469-471
Authors:
Mihich, E
Ehrke, MJ
Citation: E. Mihich et Mj. Ehrke, Anticancer drugs plus cytokines: immunodulation based therapies of mouse tumors, INT J IMMUN, 22(12), 2000, pp. 1077-1081
Authors:
Berleth, ES
Henn, AD
Gurtoo, HL
Wollman, R
Alderfer, JL
Mihich, E
Ehrke, MJ
Citation: Es. Berleth et al., A novel tumor necrosis factor-alpha inhibitory protein, TIP-B1, INT J IMMUN, 22(12), 2000, pp. 1137-1142
Authors:
Mihich, E
Citation: E. Mihich, New leads in cancer therapeutics: A keynote address, MEDICINA, 60, 2000, pp. 4-8
Authors:
Ehrke, MJ
Verstovsek, S
Maccubbin, DL
Ujhazy, P
Zaleskis, G
Berleth, E
Mihich, E
Citation: Mj. Ehrke et al., Protective specific immunity induced by doxorubicin plus TNF-alpha combination treatment of EL4 lymphoma-bearing C57BL/6 mice, INT J CANC, 87(1), 2000, pp. 101-109
Authors:
Mihich, E
Citation: E. Mihich, Lifeline - Enrico Mihich, LANCET, 354(9191), 1999, pp. 1742-1742
Authors:
Berleth, ES
Nadadur, S
Henn, AD
Eppolito, C
Shiojiri, S
Gurtoo, HL
Ehrke, MJ
Mihich, E
Citation: Es. Berleth et al., Identification, characterization, and cloning of TIP-B1, a novel protein inhibitor of tumor necrosis factor-induced lysis, CANCER RES, 59(21), 1999, pp. 5497-5506
Risultati:
1-10
|